descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 1983 English Publisher:Elsevier BVJournal:Psychiatric Clinics of North America, volume 6, pages 377-391 (issn: 0193-953X,

Authors: P A, Berger; J D, Barchas;

doi: 10.1016/s0193-953x(18)30812-8

pmid: 6316299

Pharmacologic Studies of Beta-Endorphin in Psychopathology

- Summary
- Subjects
- Metrics

Abstract

The pharmacologic trials of beta-endorphin in the field of mental illness are critically reviewed in this article, with an emphasis on the therapeutic efficacy of beta-endorphin in schizophrenia and affective disorders.

Related Organizations

Stanford University
United States

Keywords

Adult, Male, Psychiatric Status Rating Scales, Clinical Trials as Topic, Depressive Disorder, Chemical Phenomena, beta-Endorphin, Electroencephalography, Middle Aged, Prolactin, Chemistry, Double-Blind Method, Psychotic Disorders, Injections, Intravenous, Schizophrenia, Humans, Endorphins, Injections, Spinal

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	6
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average